Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 3
2006 4
2008 1
2009 2
2010 2
2012 3
2013 3
2015 2
2016 6
2017 3
2018 4
2019 3
2020 6
2021 5
2022 3
2023 4
2024 3
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Real-world patterns of post-progression treatment and outcomes in patients with HR+/HER2- advanced breast cancer treated with CDK4/6 inhibitors.
Torrisi R, Giugliano F, Giordano L, Saltalamacchia G, Jacobs F, Schianca AC, Milano M, Bianco N, Sangalli CA, De Sanctis R, Masci G, Curigliano G, Santoro A, Munzone E. Torrisi R, et al. Among authors: masci g. Oncologist. 2026 Jan 10:oyag003. doi: 10.1093/oncolo/oyag003. Online ahead of print. Oncologist. 2026. PMID: 41520162 Free article.
Baseline Hemostatic Biomarker Assessment Identifies Breast Cancer Patients at High Risk for Venous Thromboembolism During Chemotherapy.
Marchetti M, Gomez-Rosas P, Russo L, Tartari CJ, Bolognini S, Ticozzi C, Romeo D, Schieppati F, Barcella L, Sarmiento R, Masci G, Gasparini G, De Braud F, Tondini C, Santoro A, Petrelli F, Giuliani F, D'Alessio A, Labianca R, Falanga A; HYPERCAN Investigators. Marchetti M, et al. Among authors: masci g. Cancers (Basel). 2025 Aug 20;17(16):2712. doi: 10.3390/cancers17162712. Cancers (Basel). 2025. PMID: 40867341 Free PMC article.
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.
Jacobs F, Gaudio M, Andreottola C, Borroni R, Benvenuti C, Saltalamacchia G, Gerosa R, Canzian J, Tiberio P, Torrisi R, Masci G, Miggiano C, Zambelli A, Santoro A, De Sanctis R. Jacobs F, et al. Among authors: masci g. Oncologist. 2025 Jun 4;30(6):oyaf123. doi: 10.1093/oncolo/oyaf123. Oncologist. 2025. PMID: 40504547 Free PMC article.
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.
Gomez-Rosas P, Nagy M, Spronk HMH, Russo L, Gamba S, Tartari CJ, Bolognini S, Ticozzi C, Schieppati F, Sarmiento R, De Braud F, Masci G, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Santoro A, Gasparini G, Labianca R, Cate HT, Falanga A, Marchetti M; HYPERCAN Investigators. Gomez-Rosas P, et al. Among authors: masci g. J Thromb Haemost. 2025 Jun;23(6):1908-1919. doi: 10.1016/j.jtha.2025.02.029. Epub 2025 Mar 6. J Thromb Haemost. 2025. PMID: 40056983
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial.
Stefanini G, Carlo-Stella C, Cannata F, Chiarito M, Figliozzi S, Novelli L, Lisi C, Bombace S, Catapano F, Indolfi E, Panico C, Corrado F, Masci G, Mazza R, Ricci F, Monti L, Ferrante G, Reimers B, Santoro A, Francone M, da Costa BR, Jüni P, Condorelli G. Stefanini G, et al. Among authors: masci g. Cardiovasc Res. 2025 Apr 22;121(2):227-229. doi: 10.1093/cvr/cvae266. Cardiovasc Res. 2025. PMID: 39842858 Free PMC article. No abstract available.
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer.
Saltalamacchia G, Torrisi R, De Sanctis R, Masci G, Miggiano C, Gaudio M, Benvenuti C, Jacobs F, Gerosa R, Santoro A, Zambelli A. Saltalamacchia G, et al. Among authors: masci g. Biomedicines. 2024 Feb 23;12(3):500. doi: 10.3390/biomedicines12030500. Biomedicines. 2024. PMID: 38540113 Free PMC article. Review.
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Gerosa R, De Sanctis R, Jacobs F, Benvenuti C, Gaudio M, Saltalamacchia G, Torrisi R, Masci G, Miggiano C, Agustoni F, Pedrazzoli P, Santoro A, Zambelli A. Gerosa R, et al. Among authors: masci g. Crit Rev Oncol Hematol. 2024 Apr;196:104324. doi: 10.1016/j.critrevonc.2024.104324. Epub 2024 Mar 8. Crit Rev Oncol Hematol. 2024. PMID: 38462150 Free article. Review.
A New Risk Prediction Model for Venous Thromboembolism and Death in Ambulatory Lung Cancer Patients.
Gomez-Rosas P, Giaccherini C, Russo L, Verzeroli C, Gamba S, Tartari CJ, Bolognini S, Ticozzi C, Schieppati F, Barcella L, Sarmiento R, Masci G, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Minelli M, De Braud F, Santoro A, Labianca R, Gasparini G, Marchetti M, Falanga A, On Behalf Of The Hypercan Investigators. Gomez-Rosas P, et al. Among authors: masci g. Cancers (Basel). 2023 Sep 15;15(18):4588. doi: 10.3390/cancers15184588. Cancers (Basel). 2023. PMID: 37760562 Free PMC article.
62 results